Our results were supportive of individuals with the metabolically healthy/overweight phenotype being at lower colorectal cancer risk than those with hyperinsulinaemia and suggest that the assessment of insulin level in conjunction with adiposity measures may be of greater value in the assessment of colorectal cancer risk than adiposity per se. This evidence concerns the gene INS and colorectal cancer.